Tirzepatide News | Live Feed & Top Stories

Tirzepatide

In the last 4 hours

Metro.co.uk17:36

In the last 6 hours

MailOnline15:31

Earlier today

MailOnline06:31

Knowridge Science Report06:26

Yesterday

The Telegraph, Calcutta22:40 18-Jul-25

The Mirror19:37 18-Jul-25

People18:47 18-Jul-25

Victoria Buzz18:11 18-Jul-25

Business Wire (Press Release)16:18 18-Jul-25

American Journal of Managed Care15:30 18-Jul-25

The Mirror14:38 18-Jul-25

The Economic Times13:57 18-Jul-25

Zacks10:46 18-Jul-25

Macdonald-Laurier Institute10:40 18-Jul-25

Pharmacy Times10:07 18-Jul-25

Pharmacy Times09:57 18-Jul-25

Knowridge Science Report06:30 18-Jul-25

In the last 7 days

CBC.ca21:22 17-Jul-25

Pursuit20:49 17-Jul-25

My Coast Now19:01 17-Jul-25

Pique Newsmagazine18:09 17-Jul-25

The Province, British Columbia17:48 17-Jul-25

Business Wire (Press Release)12:24 17-Jul-25

Knowsley News11:31 17-Jul-25

Zacks10:51 17-Jul-25

Wales Online08:41 17-Jul-25

Wales Online06:38 17-Jul-25

Yahoo! UK & Ireland01:55 17-Jul-25

LADbible14:42 16-Jul-25

Forbes12:01 16-Jul-25

Mint08:23 16-Jul-25

MailOnline07:17 16-Jul-25

Glasgow Evening Times06:11 16-Jul-25

Knowridge Science Report06:08 16-Jul-25

The Mirror05:55 16-Jul-25

Quartz05:05 16-Jul-25

Australian Financial Review18:57 15-Jul-25

MailOnline15:44 15-Jul-25

Drug Topics15:31 15-Jul-25

The Times of India15:00 15-Jul-25

Vice (UK)14:37 15-Jul-25

HealthDay12:03 15-Jul-25

Science Media Centre11:16 15-Jul-25

Plymouth Live11:10 15-Jul-25

ITV11:09 15-Jul-25

Evening Standard11:04 15-Jul-25

Zacks09:35 15-Jul-25

pharmaphorum08:32 15-Jul-25

LADbible07:57 15-Jul-25

PR Newswire (Press Release)07:30 15-Jul-25

LADbible06:45 15-Jul-25

News-Medical.Net01:06 15-Jul-25

News-Medical.Net23:34 14-Jul-25

PR Newswire (Press Release)19:04 14-Jul-25

MailOnline18:19 14-Jul-25

New Scientist17:02 14-Jul-25

Gizmodo15:03 14-Jul-25

American Journal of Managed Care13:20 14-Jul-25

The Nittany Turkey (Weblog)12:54 14-Jul-25

NewsMax09:26 14-Jul-25

American Journal of Managed Care08:56 14-Jul-25

American Journal of Managed Care08:25 14-Jul-25

Medpage Today02:46 14-Jul-25

News-Medical.Net09:47 13-Jul-25

MailOnline19:41 12-Jul-25

Newswise (Press Release)15:31 12-Jul-25

LADbible12:08 12-Jul-25

LADbible06:31 12-Jul-25

In the last month

PakTribune13:19 11-Jul-25

Tyla09:27 11-Jul-25

LADbible07:47 11-Jul-25

American Journal of Managed Care07:22 11-Jul-25

FoodManufacture.co.uk07:05 11-Jul-25

The Times of India04:22 11-Jul-25

Zacks11:11 10-Jul-25

American Journal of Managed Care10:01 10-Jul-25

The Telegraph & Argus08:45 10-Jul-25

British Medical Journal08:22 10-Jul-25

York Press04:36 10-Jul-25

The Tony Blair Institute for Global Change04:32 10-Jul-25

American Journal of Managed Care16:03 9-Jul-25

Benzinga15:06 9-Jul-25

American Journal of Managed Care14:52 9-Jul-25

LADbible13:58 9-Jul-25

Zacks12:57 9-Jul-25

American Journal of Managed Care09:17 9-Jul-25

PR Newswire (Press Release)08:31 9-Jul-25

pharmaphorum06:32 9-Jul-25

Pharmacy Times14:38 8-Jul-25

LADbible10:28 8-Jul-25

The Columbian, Washington09:09 8-Jul-25

Forbes07:08 8-Jul-25

Lynn News06:22 8-Jul-25

News-Medical.Net22:46 7-Jul-25

The Tribune, California22:05 7-Jul-25

Latin Times21:28 7-Jul-25

Korea Biomedical Review21:18 7-Jul-25

SAMAA15:49 7-Jul-25

Medpage Today13:27 7-Jul-25

Anglia Ruskin University12:23 7-Jul-25

LADbible11:33 7-Jul-25

Reuters11:24 7-Jul-25

The Business Standard10:10 7-Jul-25

Firstpost10:07 7-Jul-25

PR Newswire (Press Release)09:02 7-Jul-25

The Business Standard07:26 7-Jul-25

Pulse06:14 7-Jul-25

Business Insider06:08 7-Jul-25

British Medical Journal05:31 7-Jul-25

i News11:40 6-Jul-25

Liverpool Echo10:40 6-Jul-25

MailOnline04:22 6-Jul-25

view more headlines

19 Jul 17:36

About our Tirzepatide news

Latest news on Tirzepatide, a drug that is being developed as a potential treatment for obesity and type 2 diabetes. It is a synthetic hormone that is designed to mimic the effects of natural hormones called incretins, which help to lower blood sugar and reduce appetite. Tirzepatide has shown promise in clinical trials, producing significant weight loss in people with obesity or type 2 diabetes. It is administered as a once-weekly injection, and it is believed to work by increasing the production of a hormone called GLP-1, which helps to regulate appetite and insulin production. Tirzepatide is currently in late-stage clinical trials, and it is expected to be considered for regulatory approval in the coming years.

正妹AV

Tirzepatide

About our Tirzepatide news

Health Top Stories

Lifestyle Top Stories